Brivaracetam impurity 111 CAS CATO-C4X-2007111

Purity 97%+In StockPharmacopoeial Impurity Standards
CAS No.CATO-C4X-2007111
Molecular FormulaC7H12O3
Molecular Weight144.17 g/mol
CategoryPharmacopoeial Impurity Standards / EP Impurities
AvailabilityIn Stock

Chemical Structure

Brivaracetam impurity 111 CAS CATO-C4X-2007111 chemical structure

Description

Under current pharmacopoeial and regulatory frameworks, quality-control requirements for this class of reference material explicitly involve the control of targets including Brivaracetam impurity 111.

CATO supplies Brivaracetam impurity 111 (CAS CATO-C4X-2007111), a pharmacopoeial impurity reference standard (molecular formula C7H12O3, MW 144.17 g/mol) used for the identification and quantification of trace impurities in APIs.

The molecular framework of Brivaracetam impurity 111 (C7H12O3) is characterized by a carboxylic acid group, a hydroxyl group, an ether linkage. In reversed-phase chromatography, its retention is governed primarily by the polarity and ionization state of its functional groups, which provides a practical basis for HPLC-UV/DAD or LC-MS method development.

This reference standard supports related-substances testing and method development in line with ICH Q3A/Q3B guidance on impurity control, and is suitable for system suitability testing and forced-degradation studies.

CATO manufactures Brivaracetam impurity 111 under ISO 17034:2016 accreditation with dual CNAS and ANAB accreditation. Each batch is characterized by orthogonal methods and supplied with a full Certificate of Analysis (COA), ensuring metrological traceability.

Physical & Chemical Properties

Molecular FormulaC7H12O3
Molecular Weight144.17 g/mol
Purity97%+
StorageStore at 2-8°C, keep sealed and dry
Solubility (reference)Soluble in methanol, ethanol, DMSO, water
StabilityHygroscopic; reseal immediately after opening
Degree of Unsaturation (DBE)2.0

Related Brivaracetam Standards

Recommended Standards

Why CATO?